Skip to main content
Family Medicine
ALL Specialities
ALL Specialities
/
Family Medicine
CME
COVID-19 Updates
The Journal of Family Practice
Current Issue
Past Issues
Author Guidelines
Specialties
Addiction Medicine
Cardiology
Dermatology
Diabetes
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pain
Pediatrics
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
For Residents
Residents' Rapid Review
Multimedia
Audio
All Podcasts
Practice Alert Podcast
Video
3-in-3
Watch & Learn
Conference Coverage
Rivaroxaban no help for heart failure outcomes
Publish date:
August 27, 2018
cardnews@mdedge.com
SOURCE:
Zannad F et al. NEJM/ESC.
.
Pages
« first
1
2
Recommended Reading
MDedge Daily News: Can a nasal spray reverse suicidality?
MDedge Family Medicine
Is medical aid in dying suicide?
MDedge Family Medicine
Babies exposed to SSRIs in utero have decreased LV size
MDedge Family Medicine
FDA approval expected for CCM in heart failure patients
MDedge Family Medicine
Heart failure confers poor prognosis in rheumatoid arthritis
MDedge Family Medicine
Medicare’s bundled pay plan didn’t deliver big cost savings
MDedge Family Medicine
Ten tips for managing patients with both heart failure and COPD
MDedge Family Medicine
Incident heart failure linked to HIV infection
MDedge Family Medicine
FDA: Cancer risk low with recalled valsartan
MDedge Family Medicine
More female authors than ever in cardiology journals
MDedge Family Medicine
Cardiology
All Specialties
